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Abstract
Despite critical implications for disease dynamics and surveillance in wild long-lived species, the immune response after 
exposure to potentially highly pathogenic bacterial disease agents is still poorly known. Among infectious diseases threat-
ening wild populations, avian cholera, caused by the bacterium Pasteurella multocida, is a major concern. It frequently 
causes massive mortality events in wild populations, notably affecting nestlings of Indian yellow-nosed albatrosses (Tha-
lassarche carteri) in the Indian Ocean. If adults are able to mount a long-term immune response, this could have important 
consequences regarding the dynamics of the pathogen in the local host community and the potential interest of vaccinating 
breeding females to transfer immunity to their offspring. By tracking the dynamics of antibodies against P. multocida during 
4 years and implementing a vaccination experiment in a population of yellow-nosed albatrosses, we show that a significant 
proportion of adults were naturally exposed despite high annual survival for both vaccinated and non-vaccinated individuals. 
Adult-specific antibody levels were thus maintained long enough to inform about recent exposure. However, only low levels 
of maternal antibodies could be detected in nestlings the year following a vaccination of their mothers. A modification of the 
vaccine formulation and the possibility to re-vaccinate females 2 years after the first vaccination revealed that vaccines have 
the potential to elicit a stronger and more persistent response. Such results highlight the value of long-term observational 
and experimental studies of host exposure to infectious agents in the wild, where ecological and evolutionary processes are 
likely critical for driving disease dynamics.
Keywords Capture–mark–recapture · Disease ecology · Immuno-ecology · Maternal antibodies · Seabird · Serological 
dynamics · Survival
Introduction
The threat infectious diseases represent for biodiversity has 
recently been acknowledged and the ability to predict the 
effect of a pathogen on host populations is an important 
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challenge for conservation (Smith et al. 2009; Young et al. 
2017). However, it requires understanding the transmission 
dynamics, which can directly depend on the capacity of 
hosts to survive infection and to mount an immune response 
(Keeling and Rohani 2008). An often neglected but critical 
compartment of the host population is thus the proportion of 
individuals surviving infection. These individuals may, for 
instance, constitute a reservoir compartment (Viana et al. 
2014) or limit transmission through a herd immunity effect 
(Iverson et al. 2016). For instance, breeding females can 
mount a protective immune response and passively transmit 
it to their offspring (Boulinier and Staszewski 2008). Pro-
tection could thus potentially be transferred from surviving 
individuals to potentially highly susceptible ones. Immuno-
logical, and particularly serological, data can be especially 
useful to track past exposure and quantify epidemiological 
dynamics (e.g., Pepin et al. 2017; Borremans et al. 2016) 
while informing on host responses, notably when collected 
in longitudinal settings (i.e., repeated sampling of individu-
als; Cizauskas et al. 2014; Buzdugan et al. 2017). Such data 
can thus be used to estimate the proportion of individuals 
that survived the previous exposure to infection.
Bacterial agents known for their pathogenicity in domes-
ticated animals are commonly encountered in the wild, but 
variations in susceptibility among host populations and 
compartments of host populations are largely underesti-
mated, especially when several strains circulate (Benskin 
et al. 2009). For instance, avian cholera, caused by Pas-
teurella multocida (Pm), has been repeatedly implicated in 
mass mortality events of adult waterfowl and seabirds in the 
northern hemisphere (e.g., Descamps et al. 2012; Österblom 
et al. 2004; Wille et al. 2016), while it seems to principally 
affect nestlings in the seabird community of Amsterdam 
Island (37°49ʹS, 77°33ʹE, southern Indian Ocean) where 
recurrent epizooties have been recorded since the mid-1980s 
(Weimerskirch 2004; Bourret et al. 2018; Jaeger et al. 2018). 
In addition, some evidence suggest that exposure of water-
fowl to Pm results in a short-lived immune response (Samuel 
et al. 2003, 2005a, b), contradicting the suggested, but not 
fully explored, herd immunity effect leading to avian chol-
era epizootics fadeout in a population of common eiders 
(Somateria mollissima; Iverson et al. 2016). Hence, despite 
avian cholera being an important pathogen for both domes-
tic (Christensen and Bisgaard 2000) and wild birds, basic 
knowledge on host responses to these bacteria is insufficient 
to be able to predict its impact on wild populations.
On Amsterdam Island, avian cholera outbreaks recur-
rently affect seabirds, providing a unique opportunity to 
gain insights on the responses of long-lived hosts to such 
a pathogenic agent in the wild. Nestling die-offs appear to 
particularly affect the locally abundant but globally endan-
gered Indian yellow-nosed albatross (Thalassarche carteri; 
Weimerskirch 2004; Jaeger et al. 2018). In contrast, impact 
of the pathogen on adult albatrosses appears limited, with no 
associated effect on the population (Rolland et al. 2009) 
despite a few infected individuals found dead (Jaeger et al. 
2018). A potential disease-induced mortality of adults could 
have a strong demographic effect in such a long-lived spe-
cies. However, it is not clear if adult birds are even exposed 
to the infectious agent. Notably, the pathogen also threatens 
the endangered endemic Amsterdam albatross (Diomedea 
amsterdamensis; Rivalan et al. 2010). Indeed, the entire 
population of this endemic species breeds in relative close 
proximity to the affected yellow-nosed albatross population, 
and predating and scavenging brown skuas (Stercorarius 
antarcticus) may act as epidemiological bridges between 
the two populations (Boulinier et al. 2016).
In long-lived species such as albatrosses, antibody 
responses could be expected to persist longer than in water-
fowl, because Procellariiformes are slow-living animals, 
characterized notably by a long lifespan and a long chick-
rearing period (Lee 2006; Garnier et al. 2013; Ramos et al. 
2014). The maintenance of high individual levels of specific 
antibodies over several breeding seasons could strengthen 
herd immunity, but also allow the long-term transfer of 
potentially protective antibodies from breeding females to 
offspring via the egg yolk (Gasparini et al. 2002; Garnier 
et al. 2012). Vaccination against Pm is widely considered 
the most effective way to protect poultry flocks (Ahmad 
et al. 2014) and autogenous vaccines are routinely used to 
reduce the risk of emergence of Pm and the mortality it 
causes (Christensen and Bisgaard 2000). On Amsterdam 
Island, vaccination has proven efficient to protect yellow-
nosed albatross nestlings after direct vaccination (Bourret 
et al. 2018), while non-vaccinated nestlings appear to die 
without mounting an immune response. If vaccination of 
adults led to the maintenance of high antibody levels over 
several breeding seasons, it could open important conserva-
tion perspectives by considering the vaccination of breeding 
females to protect offspring via maternal antibody transfer 
(Garnier et al. 2012).
In this context, the goal of this study was to improve 
our understanding of the role of birds that have survived 
exposure to Pm. This was done by assessing (1) whether 
adult yellow-nosed albatrosses show serological evidence 
of exposure to Pm, and if yes, (2) whether they are able 
to survive subsequent exposure, and (3) whether they can 
mount and maintain an immune response leading to the 
transfer of antibodies from breeding females to their off-
spring. Based on the previous observations suggesting no 
impact of the epizootics on adult survival in the recent 
years (Rolland et al. 2009), we explored predictions from 
two scenarios. In a first scenario, only a small proportion 
of adults is exposed to the bacteria, for instance, if out-
breaks happen in the colony when attendance by adults 
is low (late in the breeding cycle). In that case, we would 
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expect a low-to-null seroprevalence in non-vaccinated 
adults, independently of any potential disease-induced 
mortality. In a second scenario, a significant proportion 
of adults is exposed, survive exposure because disease-
induced mortality is low, and mount a detectable immune 
response. In that case, we would expect a moderate-to-
high seroprevalence in non-vaccinated adults. Both sce-
narios would lead to a high annual survival of adults, with 
no effect of vaccination on survival, but different sero-
prevalences. In addition, if high antibody levels are main-
tained several years following vaccination, maternally 
inherited antibodies could be detected in young nestlings. 
To explore these scenarios, we assessed the proportion of 
adults mounting a humoral immune response to Pm expo-
sure, the persistence of antibody levels over several years, 
adult annual survival, and the transfer of these antibod-
ies to nestlings in both naturally exposed and vaccinated 
adult yellow-nosed albatrosses breeding on Amsterdam 
Island. To do so, we set up a capture–recapture program 
including the monitoring of both non-vaccinated and 
vaccinated breeders in a colony recurrently affected by 
avian cholera outbreaks. In addition to the recording of 
individual resighting histories, breeding adults and their 
offspring were screened for anti-Pm antibodies for 4 con-
secutive years using two different immunoassays. Consid-
ering the threat avian cholera can represent for wild bird 
populations (Descamps et al. 2012; Phillips et al. 2016; 
Uhart et al. 2017), the results of the present study may 
have important implications from basic eco-immunology 
of host–parasite interactions (Anderson and May 1991) to 
applied conservation.
Materials and methods
Study population
Fieldwork was carried out on Amsterdam Island, in Entre-
casteaux cliffs, where approximately 20,000 pairs of yel-
low-nosed albatrosses nest between September and March 
each year (Rolland et al. 2009; Electronic Supplemental 
Material [ESM] 1, Fig. S1.1). Yellow-nosed albatrosses 
lay one egg per year in the early September and eggs 
hatch in late November–mid December (Jouventin et al. 
1983). Nest attendance by adults is high until January, but 
drops thereafter. Nestlings are thus on their own on their 
nest until fledging in April, except for punctual feeding 
visits from their parents. No albatross is present in Entre-
casteaux cliffs between April and August. The study was 
focused on a naturally delimited subcolony of approxi-
mately 250 breeding pairs of yellow-nosed albatrosses.
Vaccine development
Following a process designed for the poultry industry, an 
autogenous vaccine was produced from a Pm strain isolated 
from the carcass of a sooty albatross nestling found dead in 
Entrecasteaux cliffs in 2011–2012 (strain reference D2C; 
Jaeger et al. 2018). This strain was characterized as serotype 
Heddleston 1, Namioka 7 (Bourret et al. 2018). The vac-
cine was constituted from killed bacteria of this strain mixed 
with a mineral oil adjuvant to obtain a water-in-oil emul-
sion (Ceva Biovac, France). This vaccine has been available 
since 2013. The formulation was modified in 2015 to induce 
a higher and more durable response. More details on the 
vaccine production and its use in albatross nestlings can be 
found in Bourret et al. (2018).
Field sampling and vaccination design
During the late incubation and the early chick-rearing peri-
ods (November–December) in 2013, 134 breeding adults 
from 70 nests were captured, blood-sampled (0.5–1 mL from 
the metatarsal veins), and marked with metal and alphanu-
meric  Darvic® plastic leg bands allowing individual iden-
tification without recapture. Each captured adult individual 
received a subcutaneous injection of 0.5 mL in the back 
of the neck of either the vaccine (67 “vaccinated” indi-
viduals) or a placebo (0.9% sodium chloride solution; 67 
“NaCl-injected” individuals). When observed during the 
following weeks, birds from either group were recaptured 
and blood-sampled to assess their response to injection (37 
NaCl-injected and 34 vaccinated individuals). These birds 
then also received a second injection of either NaCl or the 
vaccine. A short-time booster effect was detected by MAT 
1 year but not 2 years after vaccination (ESM 1, Fig. S3.1) 
and no effect on raw return rate 1 year after vaccination was 
recorded. Birds injected twice in 2013 were grouped with 
birds injected once in the following analyses to be conserva-
tive with regards to the inter-annual persistence of antibody 
levels following vaccination. When both partners from a nest 
were captured, they received the same treatment. Birds from 
both treatment groups were spatially mixed and distributed 
throughout the study subcolony.
All banded individual observed within the study sub-
colony during the three following breeding seasons 
(2014–2015, 2015–2016, and 2016–2017) were recaptured 
and blood-sampled to monitor the inter-annual variations of 
specific antibody level. Most of the captures occurred during 
the early chick-rearing period and no individual was sampled 
more than three times within a season.
In 2015, after obtaining the first results of the immunoas-
says quantifying the anti-Pm antibody response and inter-
annual antibody persistence (see “Results”), it was decided 
to attempt to boost the anti-Pm antibody levels of the birds 
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that had been vaccinated 2 years before. Thirteen individu-
als were injected in December 2015 with a new formula of 
the vaccine, while keeping 13 others as control (injecting 
them with NaCl). The use of the new formula of the vaccine, 
although preventing our ability to disentangle a potential 
booster effect from an effect of the new vaccine formulation, 
was motivated by the aim to maximize the potential to obtain 
the persisting levels of antibodies.
Nestlings of injected successful breeders of the 
2014–2015, 2015–2016, and 2016–2017 cohorts were 
blood-sampled at approximately 5, 10, 30, 60, and 90 days 
of age to study the transfer and decay of maternal antibod-
ies. In the absence of sexual dimorphism, adult birds were 
sexed using a molecular technique (Fridolfsson and Ellegren 
1999) for comparison of mother’s and nestling’s antibody 
levels at hatching. The age of nestlings for which hatching 
date was not known was estimated using their tarsus length 
(ESM 1, Fig. S1.2).
Captured individuals were handled on site for only a 
few minutes. Biosecurity measures were followed to avoid 
spreading infectious agents between individuals (ESM 1). 
Within hours of collection, blood samples were centrifuged 
and plasma extracted. Plasma was kept at 4 °C in the field, 
then at – 20 °C in the laboratory until analyzed. Sample 
sizes of the different treatment groups are summarized in 
ESM 1, Table S1.1.
Immunological assays
Detection of antibodies in plasma samples was used as an 
indication of exposure to Pm antigens (natural or vaccina-
tion). Until now, a single strain of Pm has been repeatedly 
isolated from dead birds, rather supporting a single intro-
duction event of the bacterium on the island (Jaeger et al. 
2018); seropositivity against Pm is thus likely to inform on 
exposure to this strain, although the circulation of other, 
potentially less pathogenic, strains cannot be excluded. 
Given the classical caveats of the use of serology in wildlife 
(Gilbert et al. 2013; e.g., test sensitivity and specificity bel-
low unity, individual heterogeneity in response), anti-Pm 
antibody levels in plasma samples were measured using two 
complementary immunoassays detecting different immuno-
globulins to maximize the probability to detect past expo-
sure events. First, specific agglutinating antibodies (mostly 
IgM and IgY) were measured using a microagglutination 
test (MAT) developed from the Pm strain D2C isolated on 
Amsterdam Island  (SEROPAST®, Ceva Biovac, France; 
see Bourret et al. 2018). Individuals were considered sero-
positive if agglutination was observed at the tenfold or more 
dilution. Results are expressed as titers (log2[last positive 
dilution/10] + 1). Second, a commercial indirect enzyme-
linked immunosorbent assay (ELISA) detecting chicken IgY 
against the Heddleston serotypes 1, 3, and 4 (ID  Screen® 
Pasteurella multocida Chicken and Turkey Indirect, IDvet, 
France) was used. Results are expressed as optical densities 
(ODs). The use of anti-chicken IgY to detect yellow-nosed 
albatross IgY has previously been validated using an experi-
mental design and the positivity threshold was adapted using 
a method relying on fitting a mixture of normal distribu-
tions to the values of ODs (see Garnier et al. 2017). The 
two assays, thus, only partly overlap in their targeted immu-
noglobulins: they detect different isotypes, directed against 
different epitopes, which may or may not be agglutinating. 
In addition, the MAT was manufactured using the Pm strain 
isolated from the field and does not rely on an intermediate 
conjugate; as such it is expected to be more sensitive and 
more specific than the ELISA to detect exposure of alba-
trosses to Pm on Amsterdam Island (ESM 1). Overall, 697 
samples collected from 134 adults and 83 nestlings were 
analyzed (ESM 1, Table S2.1).
Immunological data analyses
Annual variations in seroprevalences in “non-vaccinated 
individuals” (individuals before vaccination and NaCl-
injected individuals) were assessed based on the data col-
lected during the late incubation and early chick-rearing 
period using logistic regressions with serological status 
(seronegative or seropositive) as the response variable and 
breeding season as an explanatory variable. As many indi-
viduals were sampled several times and a large proportion 
of individuals were partners, we used generalized linear 
mixed models in the ‘lme4 ’ R package (Bates et al. 2015), 
with the individual and the nest as random effects; likelihood 
ratio test (LRT) χ2 are reported. The Wilcoxon rank-sum test 
with a Bonferroni correction was used for comparisons of 
antibody levels between groups of different treatments and 
between periods. One individual was removed from all the 
analyses because of consistent surprisingly high ODs (ESM 
1, Fig. S2.3). For the figures, the seroprevalences were cal-
culated as the proportion of individuals tested seropositive 
at least once among all tested individuals during a given 
period. Sample sizes are reported in the corresponding fig-
ures. All statistical analyses were conducted in R 3.3.3 (R 
Development Core Team 2017) and codes are available in 
ESM 2.
Capture–recapture analysis
To explore a potential effect of vaccination on the annual 
survival of breeding adults, resightings of banded individu-
als were recorded between the breeding season 2013–2014 
and 2016–2017 on the study site and analyzed in a cap-
ture–recapture framework (Lebreton et al. 1992). To increase 
the power of the analysis, 109 non-injected individuals 
newly marked in December 2014 or December 2015 as 
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part of a parallel study (Bourret et al. 2018) were included. 
Marked individuals were thus divided in three treatment 
groups: NaCl-injected, vaccinated, and non-injected. The 
capture histories of marked individuals were built as series 
of 0 s (not observed during the breeding season; i.e., dead or 
alive but not seen) and 1 s (observed at least once during the 
breeding season; i.e., alive and seen). Each pair received a 
different code and a random-effect capture–recapture model 
(Choquet et al. 2013) was used, allowing to account for the 
potential dependence of fates (survival and resighting) 
between the members of pairs. The use of such approaches 
allows to account for potentially heterogeneous resighting 
probabilities and thus limits the risk of biased estimations 
of survival probabilities. First, we used U-CARE to assess 
the goodness-of-fit of the data set to a Cormack–Jolly–Seber 
(CJS) model (Choquet et  al. 2009a). Then, individual 
resighting histories were analyzed by running a CJS model 
in E-SURGE (Choquet et al. 2009b). Our initial model 
included a fixed vaccination effect, a fixed breeding sea-
son effect plus their interaction and a pair random effect on 
resighting probability, and a fixed vaccination effect and a 
pair random effect on survival probability (Table 1). Sur-
vival probability was constrained to be constant between 
seasons to allow parameter identifiability (Little et al. 2010). 
The among pair variation in survival or resighting (θ) for the 
ith individual of pair j was modeled as follows:
where β0 is the mean survival or resighting probability on 
the logit scale and the bj’s are independent and identically 
distributed as an univariate normal distribution N(0,σ2) 
where σ2 is the variance among pairs (Choquet et al. 2013). 
Parameters were estimated by maximization of the likeli-
hood (Lebreton et al. 1992) and models including different 
fixed effects were then compared using AIC corrected for 
small sample size (AICc; Burnham and Anderson 2002). 
Random effects of pair were tested using LRTs at the 5% 
significant level following Choquet et al. (2013). In total, 
log it(휃(ij)) = 훽0 + bj,
243 individuals from 130 nests were included in the analysis, 
corresponding to 670 resighting events.
Results
Immune response after natural exposure
Evidence of natural exposure of adults to Pm was found. 
Seroprevalence according to MAT in non-vaccinated adults 
was low during the 2013–2014 breeding season (2%, 3/133; 
Fig. 1) and significantly higher during the three following 
seasons (LRT χ2 = 14.21, p < 0.01; ESM 1, Tables S3.1–2), 
reaching 33% (8/24) in 2016–2017. After 2014–2015, 7/23 
(observed/potential) seroconversion events were observed 
(ESM 1, Fig. S3.2). Seroprevalence according to ELISA 
was low and stable during the 4 years of the study, vary-
ing between 4 and 7% (LRT χ2 = 2.04, p = 1.00; ESM 1, 
Table 1  Model selection 
for survival and resighting 
probabilities of yellow-nosed 
albatrosses
Fixed effects considered: c = constant, trt = treatment (non-injected, NaCl-injected and vaccinated), t = 
breeding season. Random effect: pair. #Id.Par. is the number of identifiable parameters of the model. Addi-
tive effects are denoted by a plus symbol (+) and interactions by a dot (.)
Model Survival Resighting #Id.Par. Deviance AICc AICc weight
1 trt+pair trt.t+pair 14 603.03 631.65 0.030
2 trt+pair trt.t 13 624.73 651.27 0.000
3 trt+pair trt+pair 8 615.17 631.38 0.034
4 trt+pair t+pair 8 614.97 631.18 0.038
6 trt trt.t+pair 13 604.22 630.76 0.047
7 c trt.t+pair 11 604.65 627.04 0.302
8 c trt+pair 5 616.67 626.76 0.347
9 c t+pair 5 617.76 627.85 0.201
131133 5354 2828 22240.0
0.2
0.4
0.6
0.8
1.0
2013−2014 2014−2015 2015−2016 2016−2017
Se
ro
pr
ev
al
en
ce
MAT (agglutinating Ig targeting the D2C strain)
ELISA (IgY targeting the H1 serotype)
Fig. 1  Prevalence of anti-Pm antibodies in non-vaccinated adult yel-
low-nosed albatrosses after egg-laying measured using an MAT and 
an ELISA. Sample sizes are reported below the bars; bars represent 
the 95% CI
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Table S3). As expected, the MAT was thus more sensitive 
compared to the ELISA for detecting natural exposure.
Most NaCl-injected individuals that seroconverted 
were resighted the following years (Fig. 2c; ESM 1, Fig. 
S3.2). Regarding the persistence of specific antibody lev-
els following natural exposure, after 2014–2015, 6/10 
seroreversion events were observed based on the MAT 
results (Fig. 2c; ESM 1, Fig. S3.2). Specific antibody 
response after natural exposure may thus be short-lived at 
the inter-annual scale. Overall, these results suggest some 
exposure to Pm in 2014–2015 and the following years.
Fig. 2  Quantification of anti-Pm antibodies by MAT (a) or ELISA (b) 
before and after vaccination and individual antibody-level dynamics 
(c) in adult yellow-nosed albatrosses after injection of NaCl or of an 
autogenous vaccine. a, c MAT non-null titers were considered posi-
tive. b ELISA positivity threshold is denoted by a dashed line; sam-
ple sizes are reported below the boxes. c Titers were measured by 
MAT; each line and color represents an individual. Nest attendance 
by adults is schematized by the black and white line, the darker the 
line, the higher is the attendance
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Immune response after vaccination
The initial vaccine injection (received in 2013–2014) 
induced a strong short-lived immune response. Most indi-
viduals responded to vaccination during the weeks fol-
lowing injection (MAT: 85%, 34/40; ELISA: 61%, 22/36; 
ESM 1, Fig. S3.3). Notably, all the individuals recaptured 
3 weeks or more after vaccination were MAT-positive 
(21/21). Positive individuals after vaccination showed 
higher antibody levels in the weeks following injection 
than naturally exposed individuals (i.e., positive non-vac-
cinated individuals) during the whole study (MAT: W = 
1249, p < 0.01; ELISA: W = 168, p = 0.04; Fig. 2a, b). 
Thus, vaccination induced a strong and immediate-specific 
immune response detected by both MAT and ELISA. One 
year after vaccination (i.e., 2014–2015), 76% (38/50) of 
the recaptured vaccinated individuals had specific antibod-
ies levels detectable by MAT, with a higher proportion 
among those that had received two injections of the vac-
cine (17/20 for the birds that received two injections in 
2013 versus 14/27 for the birds that received one). At the 
same time, seroconversion was observed in 30% (17/56) 
of the recaptured non-vaccinated individuals (Fig. S3.2). 
Assuming similar exposure to the bacterium of vaccinated 
and non-vaccinated individuals and 100% seroconversion 
of vaccinated individuals, vaccinated individuals had thus 
a 0.66 probability to remain MAT-positive 1 year after vac-
cination (see detailed calculation in ESM 1). In contrast, 
seroprevalence and antibody levels measured by ELISA 
1 year after vaccination were not higher in vaccinated indi-
viduals than in NaCl-injected individuals (Fig. 2a, b; ESM 
1, Fig. S3.3), independently of the numbers of injections 
received (ESM 1, Fig. S3.1), suggesting no persistence of 
ELISA-detected antibody levels over a year after the initial 
vaccination. More precisely, the modeled vaccine response 
would suggest a peak OD ± SD of 0.29 ± 0.08 reached 26 
± 9 days after vaccination and a return to seronegativity by 
61 ± 23 days after vaccination (ESM 1, Fig. S3.5).
The new vaccine injection received 2 years after the ini-
tial vaccination induced a longer immune response. All indi-
viduals that received that injection in 2015–2016 mounted 
an immune response detectable by MAT and ELISA 1 year 
later (i.e., 2016–2017; Figs. 2c, S3.4). These individuals had 
higher specific antibody levels than 1 year after the initial 
vaccination (MAT: paired W = 36, p = 0.05, n = 10; ELISA: 
paired W = 55, p < 0.01, n = 10), and than other individuals 
that had received two injections in 2013–2014 1 year after 
vaccination (MAT: W = 147, p < 0.01, n = 27; ELISA: W = 
140, p < 0.01, n = 24). NaCl-injected and individuals vacci-
nated in 2013 but not in 2015–2016 (independently from the 
number of injections received in 2013) had lower levels of 
specific antibodies in 2016–2017 (Fig. 2a, b). This suggests 
that the injection of the newly formulated vaccine received 
2 years after the initial vaccination induced a stronger and 
more persistent immune response than the first vaccination.
Maternal transfer of antibodies
Vaccination of breeding females led to the transfer of mater-
nal antibodies to their offspring. Specific antibodies were 
detected by MAT in the first blood sample of a high propor-
tion (> 0.50) of nestlings of parents vaccinated the previ-
ous year (i.e., in the 2014–2015 cohort after vaccination 
of parents in 2013 and the 2016–2017 cohort after parents 
had received a new injection in 2015, Fig. 3a). Notably, 
within the 2014–2015 cohort, 8/9 nestlings of females that 
had received two vaccine injections the previous year (ver-
sus 2/10 for females that had received one) and, within the 
2016–2017 cohort, 4/4 nestlings of females that received a 
new vaccine injection the previous year were detected as 
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Fig. 3  Prevalence of anti-Pm antibodies in the first blood sample of 
yellow-nosed albatross nestlings (a) and antibody-level decay after 
hatching (b) measured using MAT. a Sample sizes and mean ± SD 
nestling age are reported below the boxes. b The gray line represents 
the fitted value of the generalized additive mixed model linking anti-
body level to age with nestling identity as a random effect (ESM 1); 
only nestlings with detectable levels of antibodies in their first blood 
sample are represented
 Oecologia
1 3
seropositive. A low proportion of the other nestlings were 
detected seropositive at their first blood sample (from zero 
for nestlings of non-vaccinated adults in 2014–2015 and 
2015–2016 to 2/4 for nestlings of vaccinated adults 3 years 
after vaccination). In seropositive nestlings, antibody titers 
were low at hatching, ranging from 0 to 4, and decayed after 
hatching, with most nestlings becoming seronegative by 
21 day; only one maintained a detectable antibody level for 
at least 38 days (Fig. 3b). Of all nestlings, specific antibodies 
were detected in only two of the 2016–2017 nestlings using 
ELISA (OD = 0.54 and 0.81, aged of 6 and 14 days, respec-
tively). These individuals were associated with females vac-
cinated in 2013 and 2015 who had high ODs in December 
2016 (OD = 0.47 and 1.32, respectively).
Capture–recapture analysis
Capture–recapture modeling suggested that adult survival 
was high and independent of vaccination against Pm. In 
more detail, the goodness-of-fit test suggested no lack of fit 
of the data to a CJS model (χ2 = 7.14, p = 0.21). Excluding a 
pair random effect on resighting probability (Table 1, model 
2) markedly increased the AICc value of the initial model. 
For resighting, the assumption of an absence of variance 
among the pairs (σ = 0) was rejected (σ ± SE = 5.939 ± 
2.743, p < 0.001), indicating high heterogeneity among pairs 
in resighting probability. Removing the effects of treatment 
or season on resighting (models 3 and 4 versus 1) greatly 
increased the deviance, but resulted in large model uncer-
tainty based on AICc values. Including a pair random effect 
on survival only slightly improved the deviance of the model 
compared with the treatment survival model (model 1 versus 
6). For survival, the assumption σ = 0 could not be rejected 
(σ ± SE = 0.794 ± 1.098, p = 0.137). Therefore, survival 
probabilities of individuals associated in pairs were inde-
pendent. Removing the vaccination effect on survival (model 
7) markedly decreased the AICc and a vaccination effect on 
survival was 5.7 less likely than a constant survival, sug-
gesting that adult survival was independent of vaccination 
against Pm. Model averaged resighting probabilities were 
estimated between 0.806 and 0.913 for all years and treat-
ments, and survival probability [CI 95%] was estimated at 
0.924 [0.824; 0.965].
Discussion
Despite critical implications for the understanding of dis-
ease dynamics and the implementation of potential manage-
ment strategies, temporal patterns of exposure to bacteria 
and features of host humoral responses are often unknown 
in wild populations. Here, we provide novel information 
on these issues in a system involving Pm in a population 
of a long-lived and threatened species, by having repeat-
edly sampled breeding individuals over a 4-year period. We 
found evidence of adult exposure to the pathogen despite 
high annual survival, highlighting that adults are able to sur-
vive exposure. Indeed, the adult survival of Indian yellow-
nosed albatrosses estimated in this study is close to the adult 
survival of Atlantic yellow-nosed albatrosses (Thalassarche 
chlororhynchos) estimated on Gough Island (mean ± SE 
0.92 ± 0.01), and higher than the one estimated on Tristan 
Island (0.84 ± 0.02; Cuthbert et al. 2003), from where avian 
cholera has never been reported to our knowledge. Immune 
response after exposure or vaccination was not life-long but 
long enough to provide information on the recent epizootics 
dynamics, especially when using the MAT assay specifically 
developed with the locally isolated Pm strain, suggesting 
that serology can be a useful tool to track the patterns of Pm 
exposure in the wild. In addition, the detection of specific 
antibodies in nestlings 1 year after vaccination of breed-
ing females provides insight into possible applications of 
these tools for conservation, although more work is needed 
to understand the mechanisms involved in antibody-level 
persistence.
Immune response after natural exposure
Our study shows that, despite high annual survival, a large 
proportion of adult yellow-nosed albatrosses from Amster-
dam Island are exposed to the agent of avian cholera. This 
is consistent with results in geese, suggesting that adult 
birds can survived exposure to Pm (Samuel et al. 2005a, 
b), although it had not been quantified. It, however, con-
trasts with the other waterfowl and seabird populations in 
which avian cholera induced high adult mortalities (Leotta 
et al. 2006; Descamps et al. 2012; Österblom et al. 2004; 
Wille et al. 2016). This heterogeneity is not surprising given 
what is generally known of the variability of Pm virulence 
depending on the strain and the host (Christensen and Bis-
gaard 2000). On Amsterdam Island, the previous work sug-
gests the circulation of a unique strain of Pm among sea-
birds (Jaeger et al. 2018), although more work is needed 
to confirm the lack of Pm diversity, notably by considering 
potential non-pathogenic strains circulating among healthy 
animals that could induce cross-reacting immune responses. 
Individuals surviving infection to a pathogenic agent can 
play an important role in its maintenance (Viana et al. 2014) 
and circulation at different spatial scales (Boulinier et al. 
2016) by potentially carrying it.
Observations of seroconverting and seroreverting indi-
viduals each season since 2014–2015 suggest that the 
high seroprevalences observed these years correspond 
to several outbreaks, and not just to the maintenance of 
antibodies after the 2014–2015 outbreak. Years of high 
seroprevalences (2014–2015, 2015–2016, and 2016–2017) 
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correlate with years of low fledging success recorded in 
yellow-nosed albatrosses on Amsterdam Island (Bourret 
et al. 2018; Jaeger et al. 2018), indicating that seropreva-
lence may be used to track outbreaks. In addition, low 
seroprevalences were observed in yellow-nosed albatrosses 
in the first year of the study despite the fact that Pm out-
breaks and low fledging success had been recorded in the 
previous years (Jaeger et al. 2018). This suggests that anti-
body levels reached in response to exposure to Pm may 
not persist over successive breeding seasons. Similarly, 
levels of antibodies produced by ducks after experimental 
infection wanes within a few months (Samuel et al. 2003). 
Short-lasting immunity against Pm may, thus, impact the 
dynamics of epizootics but not be sufficient to lead to fade-
outs. These results contradict what has been suggested, but 
not assessed, in eider ducks exposed to Pm in the Canadian 
Arctic (Iverson et al. 2016).
The short-lasting humoral response observed also sug-
gests that individuals might not maintain Pm infection over 
the years and that the contribution of chronically infected 
adults to the inter-annual maintenance of Pm may be lim-
ited, unless it occurs in seronegative birds. Carrying of the 
bacteria by seronegative birds has been reported in previ-
ous studies on other species (Samuel et al. 2003), but dura-
tion is not known (Wobeser 1997 for a review). The main 
affected species may also not be the sole reservoir. Studies 
on the roles of brown rats (Rattus norvegicus; Curtis 1983) 
and brown skuas, which may be year-round residents on 
the island and probably highly exposed to Pm through for-
aging, are, hence, needed. Brown skuas may notably play 
a key role as spreaders of Pm within the island (Boulinier 
et al. 2016).
Immune response after vaccination
Vaccination of adult yellow-nosed albatrosses induced an 
immune response, but detectable antibody levels dropped to 
below detection within a year in a large proportion of indi-
viduals. However, a new injection 2 years after the initial one 
using a new vaccine formulation induced high levels of anti-
bodies that were maintained over the following year. Con-
sidering the frequency of the outbreaks (indicated by low 
fledging success; Jaeger et al. 2018) and the high seropreva-
lence in non-vaccinated individuals, it is likely that most of 
the individuals have been exposed prior to vaccination. The 
observed difference in antibody-level maintenance between 
the first and second vaccine injection is thus less likely to 
be due to a booster effect than to an effect of a difference in 
the vaccine formulation, although natural (re)exposure or 
vaccination are likely inducing different responses. Overall, 
our results open perspectives regarding the maintenance of 
anti-Pm antibody levels for several years after vaccination.
Maternal transfer of antibodies
The detection of specific antibodies in nestlings of vacci-
nated females suggests that, as observed in other seabird 
host-infectious agent systems (e.g., Gasparini et al. 2002, 
Garnier et al. 2012), anti-Pm antibodies can be transferred 
from mother to offspring via the egg yolk. However, low 
antibody levels in mothers the years following the initial 
vaccination prevented the transmission of sufficient quantity 
of antibody for a potentially protective level to be maintained 
(Grindstaff 2010). Indeed, avian cholera outbreaks are usu-
ally recorded several weeks after hatching (Weimerskirch 
2004; Bourret et al. 2018). Future work should, thus, focus 
on testing different vaccination designs in breeding adults 
(notably based on different vaccine formulations and injec-
tion schedules) to assess if it is possible to induce a strong 
long-lasting immune response. Such response could lead to 
the transfer of sufficient antibody levels to nestlings over 
several breeding seasons, as observed in another procel-
lariform species (Ramos et al. 2014), to ensure potentially 
protective levels at the time of the outbreaks.
Perspectives for disease surveillance 
and management
Vaccination of wild populations, despite numerous con-
straints and keeping in mind the importance of ethical 
issues, represents a powerful conservation tool (Plumb 
et al. 2007). Vaccination programs can be developed with 
different purposes, including elimination of the infectious 
agent(s) or direct protection of a target population. On 
Amsterdam Island, attention is strongly focused on the rare 
endemic Amsterdam albatross, but other species, poten-
tially involved in Pm circulation or maintenance, also need 
to be considered. Avian cholera appears to kill thousands 
of nestlings of the locally abundant yellow-nosed alba-
tross and their immunization, active by direct vaccination 
(previously proven in Bourret et al. 2018), or passive by 
maternally transferred antibodies, could thus be a poten-
tially important management tool if maintained over series 
of years to protect several cohorts. Vaccination of parts of 
the yellow-nosed albatross local population to limit nega-
tive demographic effects and vaccination of brown skuas 
to limit the spread of the bacteria within the island or 
direct precautionary vaccination of Amsterdam albatrosses 
are possible options that could be considered. The use of 
vaccination for conservation in Procellariiformes would 
benefit from the longevity and faithfulness of individu-
als to their breeding site, which should help to strengthen 
potential local herd immunity effects. In any case, a priori 
modeling would be a useful step to determine which com-
ponents of the community may be more pertinent to vac-
cinate and with which potentially optimal design (Haydon 
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et al. 2006; Garnier et al. 2012). The results of the current 
study thus clearly open perspectives, but empirical work is 
still required regarding the potential effects of vaccination 
on shedding and nestling protection via maternal antibody 
transfer.
In addition, our study revealed that serology could be 
useful to track the circulation of a supposedly highly lethal 
disease agent in the wild. This approach is not available 
for all systems and interpretation of the results depends on 
the temporal persistence of antibodies following infection 
(Gilbert et al. 2013; Garnier and Graham 2014; Metcalf 
et al. 2016). However, recent examples have illustrated that 
serology could be useful to detect individuals surviving to 
supposedly highly lethal infectious agents (e.g., Mulangu 
et al. 2018 for the Ebola virus, Cizauskas et al. 2014 for 
the anthrax bacillus). In addition, when serological data 
are rigorously analyzed or combined with other data 
sources, they can bring valuable information on epidemio-
logical dynamics and recent advances show that, despite 
being an old tool, it still show promise (Borremans et al. 
2016; Buzdugan et al. 2017; Pepin et al. 2017).
Overall, our results highlight the value of detailed 
observational and experimental studies of the dynamics 
of host exposure to infectious agents in the wild, where 
ecological and evolutionary processes are likely critical 
for driving disease dynamics, and such knowledge may be 
useful to inform management plans.
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